Atossa Therapeutics
ATOS
#10745
Rank
C$28.67 M
Marketcap
C$2.87
Share price
2.55%
Change (1 day)
159.40%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -C$52.48 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$49.72 Million a decrease over its 2024 earnings that were of -C$36.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$52.48 Million5.55%
2025 -C$49.72 Million36.33%
2024 -C$36.47 Million-15.25%
2023 -C$43.03 Million11.62%
2022 -C$38.55 Million30.84%
2021 -C$29.47 Million15.58%
2020 -C$25.5 Million3.41%
2019 -C$24.65 Million51.16%
2018 -C$16.31 Million40.41%
2017 -C$11.62 Million27.54%
2016 -C$9.11 Million-47.49%
2015 -C$17.35 Million-17.25%
2014 -C$20.96 Million35.91%
2013 -C$15.42 Million112.3%
2012 -C$7.27 Million46.53%
2011 -C$4.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.76 B-49,745.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$2.13 B-4,056.62%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$2.08 B-3,958.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
C$59.59 M-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-C$47.09 Million-12.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-C$11.22 Million-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA